Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25) (Transforming growth factor-beta-activated kinase 1) (TGF-beta-activated kinase 1)

 M3K7_MOUSE              Reviewed;         579 AA.
Q62073;
01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
01-NOV-1996, sequence version 1.
12-SEP-2018, entry version 176.
RecName: Full=Mitogen-activated protein kinase kinase kinase 7;
EC=2.7.11.25 {ECO:0000250|UniProtKB:O43318};
AltName: Full=Transforming growth factor-beta-activated kinase 1;
Short=TGF-beta-activated kinase 1;
Name=Map3k7; Synonyms=Tak1;
Mus musculus (Mouse).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
Muroidea; Muridae; Murinae; Mus; Mus.
NCBI_TaxID=10090;
[1]
NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
PubMed=8533096; DOI=10.1126/science.270.5244.2008;
Yamaguchi K., Shirakabe K., Shibuya H., Irie K., Ohishi I., Ueno N.,
Taniguchi T., Nishida E., Matsumoto K.;
"Identification of a member of the MAPKKK family as a potential
mediator of TGF-beta signal transduction.";
Science 270:2008-2011(1995).
[2]
FUNCTION, AND INTERACTION WITH SMAD6.
PubMed=10748100; DOI=10.1074/jbc.M908622199;
Kimura N., Matsuo R., Shibuya H., Nakashima K., Taga T.;
"BMP2-induced apoptosis is mediated by activation of the TAK1-p38
kinase pathway that is negatively regulated by Smad6.";
J. Biol. Chem. 275:17647-17652(2000).
[3]
INTERACTION WITH PPM1L.
PubMed=12556533; DOI=10.1074/jbc.M211474200;
Li M.G., Katsura K., Nomiyama H., Komaki K., Ninomiya-Tsuji J.,
Matsumoto K., Kobayashi T., Tamura S.;
"Regulation of the interleukin-1-induced signaling pathways by a novel
member of the protein phosphatase 2C family (PP2Cepsilon).";
J. Biol. Chem. 278:12013-12021(2003).
[4]
FUNCTION, UBIQUITINATION, AND PROTEASOMAL DEGRADATION.
PubMed=16157589; DOI=10.1074/jbc.M505671200;
Kaur S., Wang F., Venkatraman M., Arsura M.;
"X-linked inhibitor of apoptosis (XIAP) inhibits c-Jun N-terminal
kinase 1 (JNK1) activation by transforming growth factor beta1 (TGF-
beta1) through ubiquitin-mediated proteosomal degradation of the TGF-
beta1-activated kinase 1 (TAK1).";
J. Biol. Chem. 280:38599-38608(2005).
[5]
UBIQUITINATION, INTERACTION WITH CYLD, AND DEUBIQUITINATION BY CYLD.
PubMed=17548520; DOI=10.1084/jem.20062694;
Reiley W.W., Jin W., Lee A.J., Wright A., Wu X., Tewalt E.F.,
Leonard T.O., Norbury C.C., Fitzpatrick L., Zhang M., Sun S.C.;
"Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-
dependent kinase Tak1 and prevents abnormal T cell responses.";
J. Exp. Med. 204:1475-1485(2007).
[6]
INTERACTION WITH VRK2 AND MAPK8IP1.
PubMed=17709393; DOI=10.1128/MCB.00025-07;
Blanco S., Santos C., Lazo P.A.;
"Vaccinia-related kinase 2 modulates the stress response to hypoxia
mediated by TAK1.";
Mol. Cell. Biol. 27:7273-7283(2007).
[7]
REVIEW ON ACTIVITY REGULATION.
PubMed=17496917; DOI=10.1038/sj.onc.1210413;
Adhikari A., Xu M., Chen Z.J.;
"Ubiquitin-mediated activation of TAK1 and IKK.";
Oncogene 26:3214-3226(2007).
[8]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-412, AND IDENTIFICATION
BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Liver;
PubMed=17242355; DOI=10.1073/pnas.0609836104;
Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;
"Large-scale phosphorylation analysis of mouse liver.";
Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).
[9]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-389 AND SER-412, AND
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
PubMed=19144319; DOI=10.1016/j.immuni.2008.11.006;
Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,
Thibault P.;
"The phagosomal proteome in interferon-gamma-activated macrophages.";
Immunity 30:143-154(2009).
[10]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-389 AND SER-412, AND
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung,
Pancreas, Spleen, and Testis;
PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
"A tissue-specific atlas of mouse protein phosphorylation and
expression.";
Cell 143:1174-1189(2010).
[11]
REVIEW ON ACTIVITY REGULATION, AND REVIEW ON FUNCTION.
PubMed=20060931; DOI=10.1016/j.biocel.2009.12.023;
Landstrom M.;
"The TAK1-TRAF6 signalling pathway.";
Int. J. Biochem. Cell Biol. 42:585-589(2010).
[12]
IDENTIFICATION IN COMPLEX WITH NDFIP1 AND ITCH, AND UBIQUITINATION BY
ITCH.
PubMed=25632008; DOI=10.4049/jimmunol.1402742;
Kathania M., Zeng M., Yadav V.N., Moghaddam S.J., Yang B.,
Venuprasad K.;
"Ndfip1 regulates itch ligase activity and airway inflammation via
UbcH7.";
J. Immunol. 194:2160-2167(2015).
[13]
IDENTIFICATION IN A COMPLEX WITH SH3RF1; RAC2; MAP2K7; MAPK8IP1; MAPK8
AND MAPK9.
PubMed=27084103; DOI=10.4049/jimmunol.1501728;
Cunningham C.A., Cardwell L.N., Guan Y., Teixeiro E., Daniels M.A.;
"POSH regulates CD4+ T cell differentiation and survival.";
J. Immunol. 196:4003-4013(2016).
[14]
INTERACTION WITH PLEKHM1.
PubMed=27777970; DOI=10.1172/jci.insight.86330;
Fujiwara T., Ye S., Castro-Gomes T., Winchell C.G., Andrews N.W.,
Voth D.E., Varughese K.I., Mackintosh S.G., Feng Y., Pavlos N.,
Nakamura T., Manolagas S.C., Zhao H.;
"PLEKHM1/DEF8/RAB7 complex regulates lysosome positioning and bone
homeostasis.";
JCI Insight 1:E86330-E86330(2016).
[15]
FUNCTION, UBIQUITINATION AT LYS-158 AND LYS-209, DEUBIQUITINATION BY
CYLD, ACTIVITY REGULATION, AND MUTAGENESIS OF LYS-34; LYS-158; LYS-209
AND LYS-562.
PubMed=29291351; DOI=10.1038/nm.4461;
Ji Y.X., Huang Z., Yang X., Wang X., Zhao L.P., Wang P.X., Zhang X.J.,
Alves-Bezerra M., Cai L., Zhang P., Lu Y.X., Bai L., Gao M.M.,
Zhao H., Tian S., Wang Y., Huang Z.X., Zhu X.Y., Zhang Y., Gong J.,
She Z.G., Li F., Cohen D.E., Li H.;
"The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic
steatohepatitis.";
Nat. Med. 24:213-223(2018).
-!- FUNCTION: Serine/threonine kinase which acts as an essential
component of the MAP kinase signal transduction pathway. Plays an
important role in the cascades of cellular responses evoked by
changes in the environment. Mediates signal transduction of TRAF6,
various cytokines including interleukin-1 (IL-1), transforming
growth factor-beta (TGFB), TGFB-related factors like BMP2 and
BMP4, toll-like receptors (TLR), tumor necrosis factor receptor
CD40 and B-cell receptor (BCR) (PubMed:10748100, PubMed:16157589,
PubMed:21183079, PubMed:29291351). Ceramides are also able to
activate MAP3K7/TAK1. Once activated, acts as an upstream
activator of the MKK/JNK signal transduction cascade and the p38
MAPK signal transduction cascade through the phosphorylation and
activation of several MAP kinase kinases like MAP2K1/MEK1,
MAP2K3/MKK3, MAP2K6/MKK6 and MAP2K7/MKK7. These MAP2Ks in turn
activate p38 MAPKs, c-jun N-terminal kinases (JNKs) and I-kappa-B
kinase complex (IKK). Both p38 MAPK and JNK pathways control the
transcription factors activator protein-1 (AP-1), while nuclear
factor-kappa B is activated by IKK (PubMed:16157589,
PubMed:8533096, PubMed:29291351). MAP3K7 activates also IKBKB and
MAPK8/JNK1 in response to TRAF6 signaling and mediates BMP2-
induced apoptosis (PubMed:10748100). In osmotic stress signaling,
plays a major role in the activation of MAPK8/JNK1, but not that
of NF-kappa-B. Promotes TRIM5 capsid-specific restriction activity
(By similarity). {ECO:0000250|UniProtKB:O43318,
ECO:0000269|PubMed:10748100, ECO:0000269|PubMed:16157589,
ECO:0000269|PubMed:21183079, ECO:0000269|PubMed:29291351,
ECO:0000269|PubMed:8533096}.
-!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
{ECO:0000250|UniProtKB:O43318}.
-!- COFACTOR:
Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
-!- ACTIVITY REGULATION: Activated by proinflammatory cytokines and in
response to physical and chemical stresses, including osmotic
stress, oxidative stress, arsenic and ultraviolet light
irradiation. Activated by 'Lys-63'-linked polyubiquitination and
by autophosphorylation. Association with TAB1/MAP3K7IP1 and
TAB2/MAP3K7IP2 promotes activation through autophosphorylation,
whereas PPM1B/PP2CB, PP2A and PPP6C dephosphorylation leads to
inactivation. {ECO:0000269|PubMed:29291351}.
-!- SUBUNIT: Can form homodimer (By similarity). Binds both upstream
activators and downstream substrates in multimolecular complexes
(By similarity). Interacts with TAB1/MAP3K7IP1, TAB2/MAP3K7IP2 and
TAB3/MAP3K7IP3 (By similarity). Identified in the TRIKA2 complex
composed of MAP3K7/TAK1, TAB1/MAP3K7IP1 and TAB2/MAP3K7IP2 (By
similarity). Interacts with PPM1L and PPM1B/PP2CB
(PubMed:12556533). Interaction with PP2A and PPP6C leads to its
repressed activity (By similarity). Interacts with TRAF6 and
TAB1/MAP3K7IP1; during IL-1 signaling (By similarity). Interacts
with TAOK1 and TAOK2; interaction with TAOK2 interferes with
MAP3K7 interaction with IKKA, thus preventing NF-kappa-B
activation (By similarity). Interacts with WDR34 (via WD domains)
(By similarity). Interacts with CYLD and RBCK1 (PubMed:17548520).
Interacts with TGFBR1; induces MAP3K7/TAK1 activation by TRAF6 (By
similarity). Interacts with MAPK8IP1 and SMAD6 (PubMed:10748100,
PubMed:17709393). Interacts with isoform 1 of VRK2
(PubMed:17709393). Interacts with DAB2; the interaction is induced
by TGF-beta stimulation and may mediate TGF-beta stimulated JNK
activation (By similarity). Interacts with TRIM5 (By similarity).
Part of a complex containing ITCH, NDFIP1 and MAP3K7
(PubMed:25632008). Interacts with PLEKHM1 (via N- and C-terminus)
(PubMed:27777970). Interacts with TRIM8 (By similarity). Found in
a complex with SH3RF1, RAC2, MAP2K7/MKK7, MAPK8IP1/JIP1,
MAPK8/JNK1 and MAPK9/JNK2 (PubMed:27084103).
{ECO:0000250|UniProtKB:O43318, ECO:0000269|PubMed:10748100,
ECO:0000269|PubMed:12556533, ECO:0000269|PubMed:17548520,
ECO:0000269|PubMed:17709393, ECO:0000269|PubMed:25632008,
ECO:0000269|PubMed:27084103, ECO:0000269|PubMed:27777970}.
-!- INTERACTION:
Q9WVI9-2:Mapk8ip1; NbExp=4; IntAct=EBI-1775345, EBI-288464;
P70340:Smad1; NbExp=3; IntAct=EBI-1775345, EBI-6992047;
Q8CF89:Tab1; NbExp=2; IntAct=EBI-1775345, EBI-1778503;
Q9NYJ8:TAB2 (xeno); NbExp=2; IntAct=EBI-1775345, EBI-358708;
Q99K90:Tab2; NbExp=8; IntAct=EBI-1775345, EBI-1775124;
Q8N5C8:TAB3 (xeno); NbExp=2; IntAct=EBI-1775345, EBI-359964;
P39429:Traf2; NbExp=2; IntAct=EBI-1775345, EBI-520016;
Q86Y07-1:VRK2 (xeno); NbExp=3; IntAct=EBI-1775345, EBI-1207633;
-!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell membrane
{ECO:0000250}; Peripheral membrane protein {ECO:0000250};
Cytoplasmic side {ECO:0000250}. Note=Although the majority of
MAP3K7/TAK1 is found in the cytosol, when complexed with
TAB1/MAP3K7IP1 and TAB2/MAP3K7IP2, it is also localized at the
cell membrane. {ECO:0000250}.
-!- PTM: Association with TAB1/MAP3K7IP1 promotes autophosphorylation
and subsequent activation. Association with TAB2/MAP3K7IP2, itself
associated with free unanchored Lys-63 polyubiquitin chain,
promotes autophosphorylation and subsequent activation of MAP3K7.
Dephosphorylation at Thr-187 by PP2A and PPP6C leads to
inactivation (By similarity). {ECO:0000250}.
-!- PTM: 'Lys-48'-linked polyubiquitination at Lys-72 is induced by
TNFalpha, and leads to proteasomal degradation (PubMed:16157589).
Undergoes 'Lys-48'-linked polyubiquitination catalyzed by ITCH
(PubMed:25632008). 'Lys-63'-linked polyubiquitination at Lys-158
by TRIM8 does not lead to proteasomal degradation but contributes
to autophosphorylation and activation. Deubiquitinated by CYLD, a
protease that selectively cleaves 'Lys-63'-linked ubiquitin chains
(PubMed:17548520, PubMed:29291351). {ECO:0000250|UniProtKB:O43318,
ECO:0000269|PubMed:16157589, ECO:0000269|PubMed:17548520,
ECO:0000269|PubMed:25632008, ECO:0000269|PubMed:29291351}.
-!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
protein kinase family. MAP kinase kinase kinase subfamily.
{ECO:0000305}.
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
-----------------------------------------------------------------------
EMBL; D76446; BAA11184.1; -; mRNA.
CCDS; CCDS18014.1; -.
RefSeq; NP_766276.1; NM_172688.3.
UniGene; Mm.258589; -.
ProteinModelPortal; Q62073; -.
SMR; Q62073; -.
BioGrid; 204962; 44.
DIP; DIP-40666N; -.
IntAct; Q62073; 21.
MINT; Q62073; -.
STRING; 10090.ENSMUSP00000040307; -.
iPTMnet; Q62073; -.
PhosphoSitePlus; Q62073; -.
EPD; Q62073; -.
MaxQB; Q62073; -.
PaxDb; Q62073; -.
PRIDE; Q62073; -.
Ensembl; ENSMUST00000080933; ENSMUSP00000079734; ENSMUSG00000028284.
GeneID; 26409; -.
KEGG; mmu:26409; -.
UCSC; uc008sep.2; mouse.
CTD; 6885; -.
MGI; MGI:1346877; Map3k7.
eggNOG; KOG0192; Eukaryota.
eggNOG; COG0515; LUCA.
GeneTree; ENSGT00900000140790; -.
HOGENOM; HOG000231735; -.
HOVERGEN; HBG003485; -.
InParanoid; Q62073; -.
KO; K04427; -.
BRENDA; 2.7.11.25; 3474.
Reactome; R-MMU-168638; NOD1/2 Signaling Pathway.
Reactome; R-MMU-202424; Downstream TCR signaling.
Reactome; R-MMU-2871837; FCERI mediated NF-kB activation.
Reactome; R-MMU-4086398; Ca2+ pathway.
Reactome; R-MMU-445989; TAK1 activates NFkB by phosphorylation and activation of IKKs complex.
Reactome; R-MMU-450302; activated TAK1 mediates p38 MAPK activation.
Reactome; R-MMU-450321; JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1.
Reactome; R-MMU-5357956; TNFR1-induced NFkappaB signaling pathway.
Reactome; R-MMU-5607764; CLEC7A (Dectin-1) signaling.
Reactome; R-MMU-5689880; Ub-specific processing proteases.
Reactome; R-MMU-9020702; Interleukin-1 signaling.
Reactome; R-MMU-937042; IRAK2 mediated activation of TAK1 complex.
Reactome; R-MMU-937072; TRAF6-mediated induction of TAK1 complex within TLR4 complex.
Reactome; R-MMU-975163; IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation.
ChiTaRS; Map3k7; mouse.
PRO; PR:Q62073; -.
Proteomes; UP000000589; Chromosome 4.
Bgee; ENSMUSG00000028284; Expressed in 292 organ(s), highest expression level in heart.
CleanEx; MM_MAP3K7; -.
ExpressionAtlas; Q62073; baseline and differential.
Genevisible; Q62073; MM.
GO; GO:0005829; C:cytosol; TAS:Reactome.
GO; GO:0005622; C:intracellular; IBA:GO_Central.
GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
GO; GO:0014069; C:postsynaptic density; IDA:MGI.
GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
GO; GO:0004708; F:MAP kinase kinase activity; IDA:MGI.
GO; GO:0004709; F:MAP kinase kinase kinase activity; ISS:UniProtKB.
GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:WormBase.
GO; GO:0030971; F:receptor tyrosine kinase binding; IPI:WormBase.
GO; GO:0097110; F:scaffold protein binding; ISO:MGI.
GO; GO:0000186; P:activation of MAPKK activity; IBA:GO_Central.
GO; GO:0001525; P:angiogenesis; IMP:MGI.
GO; GO:0043276; P:anoikis; IMP:ParkinsonsUK-UCL.
GO; GO:0007252; P:I-kappaB phosphorylation; IGI:MGI.
GO; GO:0007254; P:JNK cascade; IDA:UniProtKB.
GO; GO:0000165; P:MAPK cascade; IDA:MGI.
GO; GO:2001234; P:negative regulation of apoptotic signaling pathway; IMP:MGI.
GO; GO:0060546; P:negative regulation of necroptotic process; IMP:UniProtKB.
GO; GO:2000378; P:negative regulation of reactive oxygen species metabolic process; IMP:UniProtKB.
GO; GO:1902443; P:negative regulation of ripoptosome assembly involved in necroptotic process; IGI:MGI.
GO; GO:0001841; P:neural tube formation; IMP:MGI.
GO; GO:0018107; P:peptidyl-threonine phosphorylation; IDA:WormBase.
GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IGI:MGI.
GO; GO:0046330; P:positive regulation of JNK cascade; IGI:MGI.
GO; GO:0043507; P:positive regulation of JUN kinase activity; ISS:UniProtKB.
GO; GO:0016239; P:positive regulation of macroautophagy; IMP:ParkinsonsUK-UCL.
GO; GO:0006468; P:protein phosphorylation; IDA:MGI.
GO; GO:2000377; P:regulation of reactive oxygen species metabolic process; IMP:MGI.
GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; IMP:MGI.
InterPro; IPR011009; Kinase-like_dom_sf.
InterPro; IPR017421; MAPKKK7.
InterPro; IPR000719; Prot_kinase_dom.
InterPro; IPR017441; Protein_kinase_ATP_BS.
InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
InterPro; IPR008271; Ser/Thr_kinase_AS.
PANTHER; PTHR26392:SF74; PTHR26392:SF74; 1.
Pfam; PF07714; Pkinase_Tyr; 1.
PIRSF; PIRSF038168; MAPKKK7; 1.
PRINTS; PR00109; TYRKINASE.
SMART; SM00220; S_TKc; 1.
SUPFAM; SSF56112; SSF56112; 1.
PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
1: Evidence at protein level;
Apoptosis; ATP-binding; Cell membrane; Complete proteome; Cytoplasm;
Isopeptide bond; Kinase; Magnesium; Membrane; Metal-binding;
Nucleotide-binding; Phosphoprotein; Reference proteome;
Serine/threonine-protein kinase; Stress response; Transcription;
Transcription regulation; Transferase; Ubl conjugation.
CHAIN 1 579 Mitogen-activated protein kinase kinase
kinase 7.
/FTId=PRO_0000086253.
DOMAIN 36 291 Protein kinase. {ECO:0000255|PROSITE-
ProRule:PRU00159}.
NP_BIND 42 50 ATP. {ECO:0000255|PROSITE-
ProRule:PRU00159}.
REGION 1 300 Interaction with MAPK8IP1.
{ECO:0000269|PubMed:17709393}.
COMPBIAS 8 16 Poly-Ser.
ACT_SITE 156 156 Proton acceptor. {ECO:0000255|PROSITE-
ProRule:PRU00159, ECO:0000255|PROSITE-
ProRule:PRU10027}.
BINDING 63 63 ATP. {ECO:0000255|PROSITE-
ProRule:PRU00159}.
MOD_RES 184 184 Phosphothreonine; by autocatalysis.
{ECO:0000250|UniProtKB:O43318}.
MOD_RES 187 187 Phosphothreonine; by autocatalysis.
{ECO:0000250|UniProtKB:O43318}.
MOD_RES 192 192 Phosphoserine; by autocatalysis.
{ECO:0000250|UniProtKB:O43318}.
MOD_RES 367 367 Phosphoserine.
{ECO:0000250|UniProtKB:O43318}.
MOD_RES 389 389 Phosphoserine.
{ECO:0000244|PubMed:19144319,
ECO:0000244|PubMed:21183079}.
MOD_RES 412 412 Phosphoserine.
{ECO:0000244|PubMed:17242355,
ECO:0000244|PubMed:19144319,
ECO:0000244|PubMed:21183079}.
MOD_RES 428 428 Phosphoserine.
{ECO:0000250|UniProtKB:O43318}.
CROSSLNK 72 72 Glycyl lysine isopeptide (Lys-Gly)
(interchain with G-Cter in ubiquitin).
{ECO:0000250|UniProtKB:O43318}.
CROSSLNK 158 158 Glycyl lysine isopeptide (Lys-Gly)
(interchain with G-Cter in ubiquitin).
{ECO:0000269|PubMed:29291351}.
CROSSLNK 209 209 Glycyl lysine isopeptide (Lys-Gly)
(interchain with G-Cter in ubiquitin).
{ECO:0000305|PubMed:29291351}.
MUTAGEN 34 34 K->R: No effect on ubiquitination. No
effect on induction of phosphorylation;
when associated with R-562.
{ECO:0000269|PubMed:29291351}.
MUTAGEN 158 158 K->R: Abolishes ubiquitination. Abolishes
ubiquitination and induction of
phosphorylation; when associated with R-
209. {ECO:0000269|PubMed:29291351}.
MUTAGEN 209 209 K->R: Strongly decreases ubiquitination.
Abolishes ubiquitination and induction of
phosphorylation; when associated with R-
158. {ECO:0000269|PubMed:29291351}.
MUTAGEN 562 562 K->R: No effect on ubiquitination. No
effect on induction of phosphorylation;
when associated with R-34.
{ECO:0000269|PubMed:29291351}.
SEQUENCE 579 AA; 64228 MW; 97C8F6F3C8E283EE CRC64;
MSTASAASSS SSSSASEMIE APSQVLNFEE IDYKEIEVEE VVGRGAFGVV CKAKWRAKDV
AIKQIESESE RKAFIVELRQ LSRVNHPNIV KLYGACLNPV CLVMEYAEGG SLYNVLHGAE
PLPYYTAAHA MSWCLQCSQG VAYLHSMQPK ALIHRDLKPP NLLLVAGGTV LKICDFGTAC
DIQTHMTNNK GSAAWMAPEV FEGSNYSEKC DVFSWGIILW EVITRRKPFD EIGGPAFRIM
WAVHNGTRPP LIKNLPKPIE SLMTRCWSKD PSQRPSMEEI VKIMTHLMRY FPGADEPLQY
PCQYSDEGQS NSATSTGSFM DIASTNTSNK SDTNMEQVPA TNDTIKRLES KLLKNQAKQQ
SESGRLSLGA SRGSSVESLP PTSEGKRMSA DMSEIEARIV ATAGNGQPRR RSIQDLTVTG
TEPGQVSSRS SSPSVRMITT SGPTSEKPAR SHPWTPDDST DTNGSDNSIP MAYLTLDHQL
QPLAPCPNSK ESMAVFEQHC KMAQEYMKVQ TEIALLLQRK QELVAELDQD EKDQQNTSRL
VQEHKKLLDE NKSLSTYYQQ CKKQLEVIRS QQQKRQGTS


Related products :

Catalog number Product name Quantity
18-661-15207 Mitogen-activated protein kinase kinase kinase 7 - EC 2.7.11.25; Transforming growth factor-beta-activated kinase 1; TGF-beta-activated kinase 1 Polyclonal 0.1 mg
EIAAB24864 Homo sapiens,Human,MAP kinase 11,MAP kinase p38 beta,MAPK 11,MAPK11,Mitogen-activated protein kinase 11,Mitogen-activated protein kinase p38 beta,p38-2,p38b,PRKM11,SAPK2,Stress-activated protein kinas
EIAAB41232 Map3k7ip2,Mitogen-activated protein kinase kinase kinase 7-interacting protein 2,Rat,Rattus norvegicus,Tab2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,TGF-beta-activated kinase 1-binding
EIAAB24865 MAP kinase 11,MAP kinase p38 beta,MAPK 11,Mapk11,Mitogen-activated protein kinase 11,Mitogen-activated protein kinase p38 beta,Mouse,Mus musculus,p38B,Prkm11
EIAAB25244 c-Jun N-terminal kinase kinase 2,Dual specificity mitogen-activated protein kinase kinase 7,JNK kinase 2,JNK-activating kinase 2,JNKK 2,MAP kinase kinase 7,Map2k7,MAPK_ERK kinase 7,MAPKK 7,MEK 7,Mkk7,
EIAAB25239 C-JUN N-terminal kinase kinase 1,Dual specificity mitogen-activated protein kinase kinase 4,JNK kinase 1,JNK-activating kinase 1,JNKK 1,Jnkk1,MAP kinase kinase 4,Map2k4,MAPK_ERK kinase 4,MAPKK 4,MEK 4
EIAAB25245 c-Jun N-terminal kinase kinase 2,Dual specificity mitogen-activated protein kinase kinase 7,JNK kinase 2,JNK-activating kinase 2,JNKK 2,MAP kinase kinase 7,Map2k7,MAPK_ERK kinase 7,MAPKK 7,MEK 7,Rat,R
EIAAB41234 Homo sapiens,Human,MAP3K7IP3,Mitogen-activated protein kinase kinase kinase 7-interacting protein 3,NF-kappa-B-activating protein 1,TAB3,TAB-3,TAK1-binding protein 3,TGF-beta-activated kinase 1 and MA
EIAAB24783 GCK family kinase MiNK,Map4k6,MAPK_ERK kinase kinase kinase 6,MEK kinase kinase 6,MEKKK 6,Mink,Mink1,Misshapen_NIK-related kinase,Misshapen-like kinase 1,Mitogen-activated protein kinase kinase kinase
EIAAB24784 GCK family kinase MiNK,Map4k6,MAPK_ERK kinase kinase kinase 6,MEK kinase kinase 6,MEKKK 6,Mink,Mink1,Misshapen_NIK-related kinase,Misshapen-like kinase 1,Mitogen-activated protein kinase kinase kinase
EIAAB24862 c-Jun N-terminal kinase 3,Jnk3,MAP kinase 10,MAPK 10,Mapk10,Mitogen-activated protein kinase 10,p54-beta,Prkm10,Rat,Rattus norvegicus,SAPK-beta,Stress-activated protein kinase JNK3
EIAAB24970 Leucine zipper- and sterile alpha motif kinase ZAK,Mitogen-activated protein kinase kinase kinase MLT,Mixed lineage kinase-related kinase,MLK-like mitogen-activated protein triple kinase,MLK-related k
EIAAB25246 c-Jun N-terminal kinase kinase 2,Dual specificity mitogen-activated protein kinase kinase 7,Homo sapiens,Human,JNK kinase 2,JNK-activating kinase 2,JNKK 2,JNKK2,MAP kinase kinase 7,MAP2K7,MAPK_ERK kin
EIAAB41228 Homo sapiens,Human,MAP3K7IP1,Mitogen-activated protein kinase kinase kinase 7-interacting protein 1,TAB1,TAK1-binding protein 1,TGF-beta-activated kinase 1 and MAP3K7-binding protein 1,TGF-beta-activa
10-782-55060 Mitogen-activated protein kinase 12 - EC 2.7.11.24; Extracellular signal-regulated kinase 6; ERK-6; ERK5; Stress-activated protein kinase 3; Mitogen-activated protein kinase p38 gamma; MAP kinase p38 0.05 mg
10-782-55059 Mitogen-activated protein kinase 12 - EC 2.7.11.24; Extracellular signal-regulated kinase 6; ERK-6; ERK5; Stress-activated protein kinase 3; Mitogen-activated protein kinase p38 gamma; MAP kinase p38 0.001 mg
10-782-55059 Mitogen-activated protein kinase 12 - EC 2.7.11.24; Extracellular signal-regulated kinase 6; ERK-6; ERK5; Stress-activated protein kinase 3; Mitogen-activated protein kinase p38 gamma; MAP kinase p38 0.005 mg
10-782-55059 Mitogen-activated protein kinase 12 - EC 2.7.11.24; Extracellular signal-regulated kinase 6; ERK-6; ERK5; Stress-activated protein kinase 3; Mitogen-activated protein kinase p38 gamma; MAP kinase p38 0.02 mg
10-782-55059 Mitogen-activated protein kinase 12 - EC 2.7.11.24; Extracellular signal-regulated kinase 6; ERK-6; ERK5; Stress-activated protein kinase 3; Mitogen-activated protein kinase p38 gamma; MAP kinase p38 0.01 mg
10-782-55060 Mitogen-activated protein kinase 12 - EC 2.7.11.24; Extracellular signal-regulated kinase 6; ERK-6; ERK5; Stress-activated protein kinase 3; Mitogen-activated protein kinase p38 gamma; MAP kinase p38 0.02 mg
EIAAB25240 c-Jun N-terminal kinase kinase 1,Dual specificity mitogen-activated protein kinase kinase 4,Homo sapiens,Human,JNK-activating kinase 1,JNKK,JNKK1,MAP kinase kinase 4,MAP2K4,MAPK_ERK kinase 4,MAPKK 4,M
EIAAB24870 Homo sapiens,Human,MAP kinase 13,MAP kinase p38 delta,MAPK 13,MAPK13,Mitogen-activated protein kinase 13,Mitogen-activated protein kinase p38 delta,PRKM13,SAPK4,Stress-activated protein kinase 4
EIAAB41229 Map3k7ip1,Mitogen-activated protein kinase kinase kinase 7-interacting protein 1,Mouse,Mus musculus,Tab1,TAK1-binding protein 1,TGF-beta-activated kinase 1 and MAP3K7-binding protein 1,TGF-beta-activa
EIAAB41230 Homo sapiens,Human,KIAA0733,MAP3K7IP2,Mitogen-activated protein kinase kinase kinase 7-interacting protein 2,TAB2,TAB-2,TAK1-binding protein 2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,
E1358m ELISA kit Apoptosis signal-regulating kinase 1,Ask1,ASK-1,Map3k5,MAPK_ERK kinase kinase 5,MEK kinase 5,MEKK 5,Mekk5,Mitogen-activated protein kinase kinase kinase 5,Mouse,Mus musculus 96T


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur